Skip to content

The Establishment and Optimization of Risk-predictive Model for Sleep Disorders Combined with Cardiovascular Diseases

The predictive value of contactless sleep monitoring in continuous multi-night pattern for sleep disorder and its common comorbidities

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041970
Enrollment
Unknown
Registered
2021-01-10
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorder

Interventions

Gold Standard:Clinical outcome
Index test:Risk-predictive&#32
Model&#32
for&#32
Combined&#32
with&#32

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age should be from 18 to 85 years old, regardless of gender. 2. Provide complete sleep monitoring results (the duration of single-night sleep monitoring >= 6 hours and each channel data signal is acceptable). 3. The diagnosis certificate or original report issued by an authoritative medical institution are required to confirm the existed comorbidities. 4. Provide the daily medication plan and follow the medication regularly according to the doctor's advice.

Exclusion criteria

Exclusion criteria: 1. Patients with drug-related or neurogenic sleep disorders; 2. Patients who have received PAP treatment before enrollment; 3. Patients who cannot sleep supine at night due to various reasons (this situation would affect the accuracy of signal acquisition).

Design outcomes

Primary

MeasureTime frame
Apnea-Hypopnea Index;major adverse cardiac event (MACE);

Countries

China

Contacts

Public ContactFang Fang

Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

fangfang_ff@hotmail.com+86 18811438012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026